Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
invest in seel for another 9 months, be patient and you will say :
super and easy investment/share
Seelos Therapeutics Receives a Research and Development Grant from The Michael J. Fox Foundation for Parkinson's Research for SLS-004
https://stocks.apple.com/AM7QB43SnTqKq3XVata-xyA
Yep. Nice to see it finally back over 1
But, as you say, it has a long way to go
Hopefully
still needs to go up for 150%, but it's a start, i wait for at least 4 dollar, 6 is my favorite, be patient for at least 10 months.
This isn't a good stock as to day to day trading. Recent big volume is from large non trading buys and they are holding for "something" in the wind. Low volume with a lower price isn't a big deal here.
Disappointed though with the action after market open today, premarket was so very encouraging.Consolidating maybe, hoping for better action tomorrow and rest of the week.
good call ... over a dollar right now. (1.03 at 9:00 7/11/2022)
With recent insider buys to top that too. SEEL goes past dollar mark soon.
13%, 14%, and 20%, gains ... three straight days in a row with huge volume ... (7/6/2022).
Seriously, does anyone think that something big is not about to happen???
Seems fair.
Rod hates this company so that’s good you not him.
hey, i'm not Rod and certainly not God, but Bob from belgium, i have 35 years experience on the stock market, be sure SEEL will rise the coming weeks, if not i gave you a drink in Ghent.
Pipeline updated October 2021:
SLS-002
SLS-005
SLS-004
SLS-007
https://seelostherapeutics.com/pipeline/
Seelos Therapeutics Announces FDA Acceptance of Investigational New Drug Application and Grant of Fast Track Designation for SLS-005 (IV Trehalose) for the Treatment of Spinocerebellar Ataxia
https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-SEEL/stock-news/86490794/seelos-therapeutics-announces-fda-acceptance-of-in
Sharp dip in first 30 minutes, down 6%. 2.20.
Oct. 05, 2021 Seelos Therapeutics Should Be Trading Double It's Current Stock Price As It Is Highly Likely To Be Acquired.
https://seekingalpha.com/instablog/51307855-tradeinvestments2019/5647156-seelos-therapeutics-should-be-trading-double-current-stock-price-is-highly-likely-to-be
Can’t wait for great news so flippers
are chasing with tail between their legs.
Upgrade ahead of this.....hmmmm. Somebody wants to look good by raising targets ahead of conference on the 29th. Smart move.
Cantor Virtual Global Healthcare Conference
Raj Mehra, Ph.D., Chairman and CEO, will participate in a fireside chat on Wednesday, September 29th at 10:00am ET and host 1x1 meetings via conference calls.
The fireside chat will be moderated by Charles C. Duncan, Ph.D., Senior Biotechnology Analyst at Cantor Fitzgerald.
For webcast link and replay: https://wsw.com/webcast/cantor12/seel/2075290
ty for post. Bought 1000 shares.
Big Price Target Increase!
I would be very happy if it got back to 4
$SEEL Roth Capital analyst Jonathan Aschoff upgrades Seelos Therapeutics from Neutral to Buy and raises the price target from $2.5 to $8.
That's probably correct harr449
SEEL will probably now slowly drift back to 2 or less
Buy the leak, sell the news
imo, people loaded up last week on news leak.
Sold on the news today.
I Haven't Sold Smart Money
But even with today's gain, I'm still underwater on SEEL
So hope it goes up more
Yup, AEZS next.
$1.90-2.50's= $$$$
SELL
SEEL Gets FDA clearance for SLS-005 in ALS, for Phase 2/3 trial.
https://twitter.com/TraderTexMex
SEEL been going down since stock offering was issued.
SEEL is the opposite of your MEME
it has gone from a 40 DD bra to a 28 training bra lol
it had a nice set up but looks to be fading. I hadnt entered yet.
just watching it
Nebuchadneezzar so you think there is hope for SEEL?
It has only been going down for the last half year
Maybe what goes down will bounce back up?
At the 1st of this year it had a great zig zag pattern up
but after that it has only been a knife sliding down the sloped table
Followers
|
245
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
30373
|
Created
|
09/14/05
|
Type
|
Free
|
Moderators |
Seelos Therapeutics is exploring new ways to think about and treat central nervous system (CNS) disorders in neurological diseases and disorders and in rare diseases. Our trials are designed to further evaluate the safety and efficacy of our acquired assets. These come to Seelos with well characterized efficacy and safety, thereby avoiding much of the lengthy and burdensome process of preclinical R&D.
By working with clinically ready novel and reformulated compounds we will move from asset acquisition to meaningful data readouts in an expedited and efficient fashion. It is our goal to develop unique and disruptive therapies and approaches to improve treatment of large known diseases, offer new treatments for large unmet or recently characterized indications as well as advance therapies for orphan indications.
Our approach to this process will require development that is appropriate and efficient for a company our size in the scope of work each program requires in regards to trial size and duration.
We invite you to stay update on the progress of our assets in our clinical development programs.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |